Whether your business is in early stage drug discovery and R&D or manufacturing, supply, and distribution, every part of the pharma ecosystem is now under increasing pressure to adopt sustainable practices.
NHS spending on medicines, appliances and medical devices in England hit £19.9bn in 2023/24, with £14.6bn in branded medicine sales. However, the VPAG clawback is meanwhile expected to be an unprecedented £3.5bn in 2025, £1bn more than previously forecast